Table 1.
Patient characteristics before PS matching.
| Group 1: n (%) or mean [SD] or median {IQR} | Group 2: n (%) or mean [SD] or median {IQR} | p-value (Welch /chi2-test) | |
|---|---|---|---|
| Number of patients | 55 (100) | 40 (100) | – |
| Age (years) | 54 [16] | 59 [18] | .21 |
| Male | 42 (76.4) | 27 (67.5) | .34 |
| BMI (kg/m2) | 27.1 [6.8] | 28.1 [6.1] | .48 |
| ECMO therapy d0 | 16 (30.1) | 11 (27.5) | .72 |
| SAPS II d0 | 78 [16] | 74 [18] | .21 |
| SAPS II d0 | 78 {70, 88} | 76 {63, 86} | |
| Mortality day 30 | 28 (50.9) | 22 (55.0) | .70 |
| Kidney recovery day 30 | 13 (26.6) | 4 (10.0) | .07 |
| Myoglobin d0 (ng/ml) | 38,042 [43,776] | 25,657 [19,876] | .08 |
| Myoglobin d0 (ng/ml) | 22,578 {12,391, 30,089} | 18,814 {13,030, 28,396} | |
| CK d0 (U/l) | 14,720 [28,270] | 7194 [11,411] | .07 |
| CK d0 (U/l) | 3806 {2024, 12,607} | 3818 {1687, 7644} |
BMI: body mass index; ECMO: extracorporeal membraneoxygenation; ICU: intensive care unit; SAPS: simplified acute physiology score; CK: creatine kinase; d0: study enrollment day.